Furthermore, as the tumor status changed with treatment, the expression levels of these genes changed correspondingly in PBMCs; treated HCC patients without active/residual tumor cells had higher transcript levels of CCNB1, CDC20, and CENPF compared with the other two subgroups of HCC patients (Figure 3A). This evidence concerns the gene CCNB1 and hepatocellular carcinoma.